Xiaojun Jiang
Oslo, Norway
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 18 publications
An epithelial GPR35 isoform supports tumor-associated transcriptional and metabolic phenotypes.
Journal: FEBS letters
Published: February 13, 2026
Intrahepatic T cell analysis reveals Th17 and MAIT17 enrichment in primary sclerosing cholangitis.
Journal: JHEP reports : innovation in hepatology
Published: August 21, 2025
Mucosal-Associated Invariant T Cells Drive Bile Duct Inflammation.
Journal: Cellular and molecular gastroenterology and hepatology
Published: April 11, 2025
Multimodal transcriptomics identifies metallothionein as a novel pathway in primary sclerosing cholangitis.
Journal: Hepatology (Baltimore, Md.)
Published: February 12, 2025
Natural Killer T cells promote cholestatic liver disease independent of antigen presentation by cholangiocytes.
Journal: Hepatology communications
Published: February 04, 2025
Microbial exposure during early life regulates development of bile duct inflammation.
Journal: Scandinavian journal of gastroenterology
Published: November 24, 2023
Role of bacteria and microbial metabolites in immune modulation during early life.
Journal: Scandinavian journal of immunology
Published: April 03, 2023
The Role of Natural Killer Cells in Nonalcoholic Steatohepatitis: An Ongoing Debate.
Journal: Cellular and molecular gastroenterology and hepatology
Published: October 05, 2021
Bile from Patients with Primary Sclerosing Cholangitis Contains Mucosal-Associated Invariant T-Cell Antigens.
Journal: The American journal of pathology
Published: August 06, 2021
Lipid antigens in bile from patients with chronic liver diseases activate natural killer T cells.
Journal: Clinical and experimental immunology
Published: August 23, 2020
A heterozygous germline CD100 mutation in a family with primary sclerosing cholangitis.
Journal: Science translational medicine
Published: January 22, 2020
Last Updated: 09/26/2026